Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

olopatadine ophthalmic

olopatadine ophthalmic
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Patanol SOLUTION, OPHTHALMIC 0.1%    
Pataday SOLUTION, OPHTHALMIC 0.2%    
Pazeo SOLUTION, OPHTHALMIC 0.7%    
VIEW MORE Antiallergic Agents
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

olopatadine ophthalmic (Pataday)

  • 0.2% solution ophthalmic Daily

olopatadine ophthalmic (Patanol)

  • 0.1% solution ophthalmic 1 drop BID

olopatadine ophthalmic (Pazeo)

  • 0.7% solution ophthalmic Daily

olopatadine ophthalmic (Patanol)

  • 0.1% solution ophthalmic 1 drop BID

Patanol 0.1 % ophthalmic solution is dosed twice daily and is the formulary olopatadine agent.

Pataday 0.2% and Pazeo 0.7%, dosed once daily, is classified as non-formulary. Interchange orderes for Pataday 0.2% and Pazeo 0.7% daily to Patanol 0.1% twice daily.

Reviewed: March 23, 2010.

Updated: 22 November 2016 (olopatadine ophthalmic products),  March 2025 (Patanol)

Last updated: Apr. 9, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved